These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8743648)

  • 1. The dexamethasone suppression test for diagnosing depression in stroke patients.
    Harvey SA; Black KJ
    Ann Clin Psychiatry; 1996 Mar; 8(1):35-9. PubMed ID: 8743648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of the dexamethasone suppression test in the diagnosis of poststroke depression.
    Grober SE; Gordon WA; Sliwinski MJ; Hibbard MR; Aletta EG; Paddison PL
    Arch Phys Med Rehabil; 1991 Dec; 72(13):1076-9. PubMed ID: 1741660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dexamethasone suppression test. An indicator of depression in stroke but not a predictor of rehabilitation outcome.
    Reding M; Orto L; Willensky P; Fortuna I; Day N; Steiner SF; Gehr L; McDowell F
    Arch Neurol; 1985 Mar; 42(3):209-12. PubMed ID: 3977650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosing depression after stroke.
    Black KJ
    South Med J; 1995 Jul; 88(7):699-708. PubMed ID: 7597471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone suppression test in depressive stroke patients.
    Dam H; Pedersen HE; Damkjaer M; Ahlgren P
    Acta Neurol Scand; 1991 Jul; 84(1):14-7. PubMed ID: 1927256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dexamethasone suppression test and mood following stroke.
    Lipsey JR; Robinson RG; Pearlson GD; Rao K; Price TR
    Am J Psychiatry; 1985 Mar; 142(3):318-23. PubMed ID: 3970268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone suppression test and depression in a rehabilitation setting.
    Bauer M; Gans JS; Harley JP; Cobb W
    Arch Phys Med Rehabil; 1983 Sep; 64(9):421-2. PubMed ID: 6615180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different linkage of depression to hypercortisolism early versus late after stroke. A 3-year longitudinal study.
    Aström M; Olsson T; Asplund K
    Stroke; 1993 Jan; 24(1):52-7. PubMed ID: 8418550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dexamethasone suppression test, poststroke depression, and the validity of DSM-III-based diagnostic criteria.
    Ross ED; Gordon WA; Hibbard M; Egelko S
    Am J Psychiatry; 1986 Sep; 143(9):1200-1. PubMed ID: 3752314
    [No Abstract]   [Full Text] [Related]  

  • 10. Dexamethasone suppression test and onset of poststroke depression in patients with ischemic infarction.
    Harney JH; Fulton C; Ross ED; Rush AJ
    J Clin Psychiatry; 1993 Sep; 54(9):343-8. PubMed ID: 8407853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of six depression rating scales in geriatric stroke patients.
    Agrell B; Dehlin O
    Stroke; 1989 Sep; 20(9):1190-4. PubMed ID: 2772980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone suppression test, TRH test and Newcastle II depression rating in the diagnosis of depressive disorders.
    Larsen JK; Bjørum N; Kirkegaard C; Aggernaes H; Krog-Meyer I; Lund-Laursen AM; Mikkelsen PL
    Acta Psychiatr Scand; 1985 May; 71(5):499-505. PubMed ID: 3925727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression and the dexamethasone suppression test (DST) in patients with non-specific somatic complaints. Atypical depression and DST.
    Syvälahti E; Hyyppä MT; Salminen JK
    Ann Clin Res; 1985; 17(4):148-51. PubMed ID: 4073803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mood, vegetative disturbance, and dexamethasone suppression test after stroke.
    Finklestein S; Benowitz LI; Baldessarini RJ; Arana GW; Levine D; Woo E; Bear D; Moya K; Stoll AL
    Ann Neurol; 1982 Nov; 12(5):463-8. PubMed ID: 6960804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to dexamethasone and subtype of depression.
    Brown WA; Shuey I
    Arch Gen Psychiatry; 1980 Jul; 37(7):747-51. PubMed ID: 7190379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dexamethasone suppression test in schizophrenia.
    Ismail K; Murray RM; Wheeler MJ; O'Keane V
    Psychol Med; 1998 Mar; 28(2):311-7. PubMed ID: 9572089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression in women treated for gynecological cancer: clinical and neuroendocrine assessment.
    Evans DL; McCartney CF; Nemeroff CB; Raft D; Quade D; Golden RN; Haggerty JJ; Holmes V; Simon JS; Droba M
    Am J Psychiatry; 1986 Apr; 143(4):447-52. PubMed ID: 3082223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine tests in depressive stroke patients.
    Dam H; Pedersen HE; Dige-Petersen H; Ahlgren P
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Oct; 18(6):1005-13. PubMed ID: 7824755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of four definitions of melancholia by the dexamethasone suppression test.
    Davidson J; Lipper S; Zung WW; Strickland R; Krishnan R; Mahorney S
    Am J Psychiatry; 1984 Oct; 141(10):1220-3. PubMed ID: 6486256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone suppression test and post-stroke depression.
    Agarwal A; Nag D; Kar AM; Agarwal AK; Chowdhury SR
    Indian J Med Res; 1987 Mar; 85():297-301. PubMed ID: 3610274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.